Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567281 · ClinicalTrials.gov registry record · NA
Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00567281 is a NA study that has completed, run by Yale University. The registered enrollment target is 40 participants.
The verdict
NCT00567281, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
This trial is designed to determine if administering repetitive transcranial magnetic stimulation (rTMS) simultaneously to two sites in the temporal lobes, one on the left and one on the right, produces greater improvements in "voices" and other symptoms of schizophrenia compared to rTMS given to just one site in the temporal lobes.
Interventions
- DEVICE Magstim Rapid 2 system triggering Magstim Super Rapid system
- DEVICE Magstim Rapid-2 system triggering Magstim Super Rapid system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2007-10 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00567281
The ClinicalTrials.gov registry entry for NCT00567281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Magstim Rapid 2 system triggering Magstim Super Rapid system is the first listed.
NCT00567281 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00567281 about?
NCT00567281 is a clinical study titled "Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Original Study". This trial is designed to determine if administering repetitive transcranial magnetic stimulation (rTMS) simultaneously to two sites in the temporal lobes, one on the left and one on the right, produces greater improvements in "voices" and other symptoms of schizophrenia compared to rTMS given to ju...
What is the current status of trial NCT00567281?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2007-10. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00567281?
The interventions under investigation include: Magstim Rapid 2 system triggering Magstim Super Rapid system (DEVICE), Magstim Rapid-2 system triggering Magstim Super Rapid system (DEVICE).
Who is sponsoring clinical trial NCT00567281?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.